Register
Forgot your password?

Pericardial diseases: etiology, pathophysiology,diagnosis and treatment

Authors: O.V. Kas’yanova

Company: Cardiology Chair of Moscow State University of Medicine and Dentistry named after A.I. Evdokimov of Ministry of Health of the Russian Federation, ulitsa Delegatskaya, 20/1, Moscow, 127473, Russian Federation

For correspondence:  Sign in or register.


DOI: https://doi.org/10.24022/1997-3187-2017-11-4-326-336

For citation: Kas’yanova O.V. Pericardial diseases: etiology, pathophysiology, diagnosis and treatment. Kreativnaya Kardiologiya (Creative Cardiology). 2017; 11 (4): 326–36 (in Russ.). DOI: 10.24022/1997-3187-2017-11-4-326-336

Received / Accepted:  30.05.2017/30.10.2017

Keywords: pericardial diseases etiology diagnosis treatment prognosis

Full text:  

 

Abstract

Pericardial diseases are fairly common pathology, which has to deal with doctors of various specialties, often representing difficulties in diagnosis. The article discusses the most important issues and new data based on the materials of the European Society of Cardiology for diagnosis and management of patients with pericardial disease, published in 2015.

References

  1. Maisch B., Seferović P.M., Ristić A.D., Erbel R., Rienmüller R., Adler Y. et al. Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary. Eur. Heart J. 2004; 25: 587–610.

  2. Adler Y., Charron Y., Imazio M., Badano L., Baron-Esquivias G., Bogaert J. et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC). Eur. Heart J. 2015; 36 (42): 2921–64.

  3. Guindo J. Comments on the 2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases. A Report by the Spanish Society of Cardiology Guidelines Committee Working Group. Rev. Esp. Cardiol. 2015; 68: 1068–74.

  4. Kyto V., Sipila J., Rautava P. Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis. Circulation. 2014; 130: 1601–6.

  5. Imazio M., Gaita F. Diagnosis and treatment of pericarditis. Heart. 2015; 101: 1159–68.

  6. Frisancho-Kiss S., Coronado M.J., Frisancho J.A., Lau V.M., Rose N.R., Klein S.L., Fairweather D. Gonadectomy of male BALB/c mice increases Tim-3 (+) alternatively activated M2 macrophages, Tim-3 (+) T cells, Th2 cells and Treg in the heart during acute coxsackie virus induced myocarditis. Brain. Behav. Immun. 2009; 23: 649–57.

  7. Lyden D.C., Olszewski J., Feran M., Job L.P., Huber S.A. Coxsackievirus B-3-induced myocarditis. Effect of sex steroids on viremia and infectivity of cardiocytes. Am. J. Pathol. 1987; 126: 432–8.

  8. Li Z., Yue Y., Xiong S. Distinct Th17 inductions contribute to the gender bias in CVB3-induced myocarditis. Cardiovasc. Pathol. 2013; 22: 373–82.

  9. Huber S.A. Coxsackievirus B3-induced myocarditis: Infection of females during the estrus phase of the ovarian cycle leads to activation of T regulatory cells. Virology. 2008; 378 (2): 292–8.

  10. Imazio M., Cecchi E., Demichelis B., Chinaglia A., Ierna S., Demarie D. et al. Myopericarditis versus viral or idiopathic acute pericarditis. Heart. 2008; 94: 498–501.

  11. Imazio M., Bobbio M., Cecchi E., Demarie D., Demichelis B., Pomari F. et al. Colchicine in addition to conventional therapy for acute pericarditis: results of the COlchicine for acute PEricarditis (COPE) trial. Circulation. 2005; 112: 2012–6.

  12. Imazio M., Brucato A., Cemin R., Ferrua S., Maggiolini S., Beqaraj F. et al. ICAP Investigators. A randomized trial of colchicine for acute pericarditis. N. Engl. J. Med. 2013; 369: 1522–8.

  13. Admetlla M., Cequier A., Amer R., Javaloyas M., Sabate X., Gausi C. Acute idiopathic pericarditis: clinical features, development and complications: prospective study of 101 cases. Med. Clin. (Barc.). 1985; 85: 563–7.

  14. Imazio M., Spodick D.H., Brucato A., Trinchero R., Adler Y. Controversial issues in the management of pericardial diseases. Circulation. 2010; 121: 916–28.

  15. Cosyns B., Plein S., Nihoyanopoulos P., Smiseth O., Achenbach S., Andrade M.J. et al. On behalf of the European Association of Cardiovascular Imaging (EACVI) and European Society of Cardiology Working Group (ESC WG) on Myocardial and Pericardial diseases. European Association of Cardiovascular Imaging (EACVI) position paper: multimodality imaging in pericardial disease. Eur. Heart J. Cardiovasc. Imaging. 2014; 16: 12–31.

  16. Lobert P., Brown R.K., Dvorak R.A., Corbett J.R., Kazerooni E.A., Wong K.K. Spectrum of physiological and pathological cardiac and pericardial uptake of FDG in oncology PET-CT. Clin. Radiol. 2013; 68: e59–71.

  17. Imazio M., Cecchi E., Demichelis B., Ierna S., Demarie D., Ghisio A. et al. Indicators of poor prognosis of acute pericarditis. Circulation. 2007; 115: 2739–44.

  18. Alabed S., Cabello J.B., Irving G.J., Qintar M., Burls A. Colchicine for pericarditis. Cochrane Database Syst. Rev. 2014; 8: CD010652.

  19. Pelliccia A., Corrado D., Bjo⁄ rnstad H.H., Panhuyzen-Goedkoop N., Urhausen A., Carre F. et al. Recommendations for participation in competitive sport and leisure-time physical activity in individuals with cardiomyopathies, myocarditis and pericarditis. Eur. J. Cardiovasc. Prev. Rehabil. 2006; 13: 876–85.

  20. Imazio M., Brucato A., Cumetti D., Brambilla G., Demichelis B., Ferro S. et al. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation. 2008; 118: 667–71.

  21. Imazio M., Adler Y. Management of pericardial effusion. Eur. Heart J. 2013; 34: 1186–97.

  22. Imazio M., Brucato A., Maestroni S., Cumetti D., Dominelli A., Natale G., Trinchero R. Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation. 2011; 123: 1092–7.

  23. Alraies M.C., AlJaroudi W., Yarmohammadi H., Yingchoncharoen T., Schuster A., Senapati A. et al. Usefulness of cardiac magnetic resonance-guided management in patients with recurrent pericarditis. Am. J. Cardiol. 2015; 115: 542–7.

  24. Imazio M., Belli R., Brucato A., Cemin R., Ferrua S., Beqaraj F. et al. Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, doubleblind, placebo-controlled, randomized trial. Lancet. 2014; 383: 2232–7.

  25. Imazio M., Bobbio M., Cecchi E., Demarie D., Pomari F., Moratti M. et al. Colchicine as firstchoice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. Arch. Intern. Med. 2005; 165: 1987–91.

  26. Lotrionte M., Biondi-Zoccai G., Imazio M., Castagno D., Moretti C., Abbate A. et al.International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences. Am. Heart J. 2010; 160: 662–70.

  27. Brucato A., Brambilla G., Moreo A., Alberti A., Munforti C., Ghirardello A. et al. Longterm outcomes in difficult-to-treat patients with recurrent pericarditis. Am. J. Cardiol. 2006; 98: 267–71.

  28. Khandaker M.H., Schaff H.V., Greason K.L., Anavekar N.S., Espinosa R.E., Hayes S.N. et al. Pericardiectomy vs medical management in patients with relapsing pericarditis. Mayo Clin. Proc. 2012; 87: 1062–70.

  29. Imazio M., Brucato A., Barbieri A., Ferroni F., Maestroni S., Ligabue G. et al. Good prognosis for pericarditis with and without myocardial involvement: results from a multicenter, prospective cohort study. Circulation. 2013; 128: 42–9.

  30. Imazio M., Brucato A., Spodick D.H., Adler Y. Prognosis of myopericarditis as determined from previously published reports. J. Cardiovasc. Med. (Hagerstown). 2014; 15: 835–9.

  31. Imazio M., Brucato A., Barbieri A., Ferroni F., Maestroni S., Ligabue G. et al. Good prognosis for pericarditis withand without myocardial involvement: results from a multicenter, prospective cohortstudy. Circulation. 2013; 128: 42–9.

  32. Imazio M., Brucato A., Belli R., Forno D., Ferro S., Trinchero R., Adler Y. Colchicine for the prevention of pericarditis: what we know and what we do not know in 2014 – systematic review and meta-analysis. J. Cardiovasc. Med. (Hagerstown). 2014; 15: 840–6.

  33. Mitiku T.Y., Heidenreich P.A. A small pericardial effusion is a marker of increased mortality. Am. Heart J. 2011; 161: 152–7.

  34. Ristić A.D., Imazio M., Adler Y., Anastasakis A., Badano L.P., Brucato A. et al. Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 2014; 35: 2279–84.

  35. Imazio M., Brucato A., Adler Y., Brambilla G., Artom G., Cecchi E. et al. Prognosis of idiopathic recurrent pericarditis as determined from previously published reports. Am. J. Cardiol. 2007; 100: 1026–8.

  36. Mayosi B.M., Burgess L.J., Doubell A.F. Tuberculous pericarditis. Circulation. 2005; 112: 3608–16.

  37. Imazio M., Brucato A., Mayosi B.M., Derosa F.G., Lestuzzi C., Macor A. et al. Medical therapy of pericardial diseases: part II: noninfectious pericarditis, pericardial effusion and constrictive pericarditis. J. Cardiovasc. Med. (Hagerstown). 2010; 11: 785–94.

  38. DeValeria P.A., Baumgartner W.A., Casale A.S., Greene P.S., Cameron D.E., Gardner T.J. Current indications, risks, and outcome after pericardiectomy. Ann. Thorac. Surg. 1991; 52: 219–24.

  39. Mayosi B.M., Ntsekhe M., Volmink J.A., Commerford P.J. Interventions for treating tuberculous pericarditis. Cochrane Database Syst. Rev. 2002; 4: CD000526.

  40. Geggel R.L. Conditions leading to pediatric cardiology consultation in a tertiary academic hospital pediatrics. Pediatrics. 2004; 114: 409–17.

  41. Shakti D., Hehn R., Gauvreau K., Sundel R.P., Newburger J.W. Idiopathic pericarditis and pericardial effusion in children: contemporary epidemiology and management. J. Am. Heart Assoc. 2014; 3: e001483.

  42. Imazio M., Brucato A., Pluymaekers N., Breda L., Calabri G., Cantarini L. et al. Recurrent pericarditis in children and adolescents: etiology, presentation, therapies, and outcomes. A multicenter cohort study. J. Cardiovasc. Med. 2016; 17 (9): 707–12.

  43. Picco P., Brisca G., Traverso F., Loy A., Gattorno M., Martini A. Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1β receptor antagonist (anakinra): an unrecognized autoinflammatory disease? Arthritis Rheum. 2009; 60: 264–8.

  44. Ristić A.D., Seferović P.M., Ljubić A., Jovanović I., Ristić G., Pankuweit S. et al. Pericardial disease in pregnancy. Herz. 2003; 28: 209–15.

  45. Brucato A., Imazio M., Curri S., Palmieri G., Trinchero R. Medical treatment of pericarditis during pregnancy. Int. J. Cardiol. 2010; 144: 413–4.

  46. Pasina L., Brucato A.L., Falcone C., Cucchi E., Bresciani A., Sottocorno M. et al. Medicationn on-adherence among elderly patients newly discharged and receiving polypharmacy. Drugs Aging. 2014; 31: 283–9.

About Authors

Kas’yanova Ol’ga Vladimirovna, Cand. Med. Sc., Assistant Professor, orcid.org/0000-0002-0620-2119

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery


Sort by